We are pleased to invite investors and analysts to participate in a live webinar on Wednesday,
17 November 2021, highlighting Roche's development in digital technology, data and advanced analytics.
16:00 - 17:30 CET / 15:00 - 16:30 GMT
10:00 - 11:30 am EST / 07:00 - 08:30 am PST
The webinar will be hosted by Alan Hippe, Chief Financial and IT Officer, and other senior leaders in the space followed by a Q&A session.
The event will outline the overall strategy and highlight >20 use cases (including launched products) from the pharmaceuticals & diagnostics divisions. Use cases presented will cover the entire traditional value chain (early R&D, clinical development, regulatory & reimbursement, manufacturing, commercialization, diagnosis) as well as novel treatment/decision support solutions for physicians and patients.
Presenters include:
- Alan Hippe, Chief Financial and IT Officer Roche
- Mark McCarthy, Executive Director, Human Genetics, gRED
- Christian Gossens, Digital Biomarkers, Global Area Head, pRED
- Jacqueline Law, Vice president, Head of Corporate Strategy, Flatiron Health
- Steve Guise, Global Head, Pharma Informatics
- Moritz Hartmann, Global Head of Roche Information Solutions, Roche Diagnostics
The slides will be available for download at 15:00 CET on the day of the event. > click here
We would like to invite all interested parties to participate in the webinar and to pre-register here.*
Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.
A replay of the webcast will be available via > ir.roche.com
*privacy notice |
Best regards,
Karl Mahler
Head of Investor Relations
|
Bruno Eschli
Investor Relations Officer
|
Gerard Tobin
Investor Relations Officer
|
